<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158182">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02050893</url>
  </required_header>
  <id_info>
    <org_study_id>fluid responsiveness</org_study_id>
    <nct_id>NCT02050893</nct_id>
  </id_info>
  <brief_title>The Effect of Midazolam on Fluid Responsiveness in Septic Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid resuscitation remains the foundation for septic treatment.The evaluation of fluid
      responsiveness has significance in volume resuscitation for septic shock patients. As the
      sedative which is commonly used in ICU, Midazolam is supposed to change fluid responsiveness
      for the pharmacological effect of venodilation. However, the hypothesis has not been
      certified clinically. In this research, the investigators aim to test the hypothesis that
      Midazolam can increase fluid responsiveness(using passive leg raising test) in septic shock
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>percentage of participants with more than 10% increase of cardiac index by passive leg raising after sedation</measure>
    <time_frame>Baseline,after sedation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midazolam infused at a 0.03mg/kg loading dose ,and 0.02-0.1mg/kg.h maintenance dose to achieve Ramsay score of 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol infuse at a loading dose of 0.5mg/kgï¼Œand 0.5-2.0mg/kg.h maintenance dose to achieve Ramsay score of 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sedatives(Midazolam and Propofol)</intervention_name>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patients are included if they meet the following inclusion criteria:

          1. Above 18 years old

          2. Endotracheal intubated and mechanical ventilated

          3. Awake, can communicate with researchers

          4. Diagnosed as septic shock. The definition of septic shock was clarified in Year 2001
             ACCP/SCCM guidelines

          5. Within 24 hours after the EGDT resuscitation goals are achieved

          6. Informed consent are signed.

        Exclusion Criteria

          1. Under 18 years old

          2. Intra-abdominal hypertension

          3. Central nerves system dysfunction

          4. Heart failure and other cardiac dysfunction such as cardiac conduction block,acute
             coronary syndrome, cardiogenic shock

          5. Proof of volume overload or contradiction of fluid infusion

          6. Existence of arterial aneurysm, serious valvular disease,extensive peripheral
             vascular occlusion disease and insertion of artificial pacemaker
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Critical Care , Zhong-da Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>(86)210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>March 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>Department of critical care medicine, Zhongda Hospital</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>sepsis</keyword>
  <keyword>fluid responsiveness</keyword>
  <keyword>Midazolam</keyword>
  <keyword>Propofol</keyword>
  <keyword>haemodynamics</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Hypnotics and Sedatives</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
